Social Return on Investment of an ideal approach to Multiple Sclerosis within the SNHS

Congress: ISPOR Year: 2018 Desease: Neurological Disorders Subject: Cost Studies Subcategory:Cost Benefit Analysis Objectives:Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system, characterized by progression and disability and a high impact on patients’ health-related quality of life. This study measures the Social Return on Investment (SROI) of the hypothetical implementation of […]

Pharmacoeconomic assessment of Pegaspargase versus Asparaginase in acute lymphocytic leukemia

Congress: ISPOR Europe 2016 Year: 2016 Disease: Oncology Subcategory: Minimization of costs Objective: To perform a cost minimization analysis comparing the costs of native asparaginase therapy versus pegaspargase therapy in patients diagnosed with acute lymphoblastic leukemia (ALL) from the perspective of the National Health System. The study is supported by Shire. DOI: https://doi.org/10.1016/j.jval.2016.09.2243